We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more

Resource Library


[Industry Voice #29] QL Biopharm's Vision for the Future of Chronic Metabolic Diseases

In our new Industry Voice video podcast episode, join OCT Clinical in discussing the future of chronic metabolic diseases alongside QL Biopharm, a pioneering drug manufacturing company from China. Discover the cutting-edge insights and innovative strategies that QL Biopharm brings to the table, aiming to transform the landscape of chronic metabolic diseases and pharma market in China and around the globe.



Thank you for your request!
Our team will respond to you within 24 hours.